Asia Pacific HIV Diagnostics Market Growth Accelerated by Rising Prevalence of HIV/AIDS


 Asia Pacific HIV diagnostics market comprises devices and kits that are used to detect the presence of HIV in the human body. HIV diagnostic tests help detect antibodies or antigens that are generated when the body fights against HIV infection. These tests play a pivotal role in HIV screening of blood, tissues, cells, and organs donated for transfusions or transplants. They are also used to confirm an HIV infection in a person with signs or symptoms, and can determine the stage of HIV infection. The global Asia Pacific HIV Diagnostics Market is estimated to be valued at US$ 522.5 Mn in 2023 and is expected to exhibit a CAGR of 12.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market key trends:
The prevalence of HIV/AIDS has been steadily rising in the Asia Pacific region over the past few decades. As per UNAIDS estimates, there were around 4.5 million people living with HIV in Asia Pacific as of 2020. East and South-East Asia including countries like China, Thailand, and Indonesia have a high burden of HIV compared to other regions. This high patient pool suffering from HIV/AIDS is driving significant demand for advanced HIV diagnostic tests in the region. Moreover, increasing public awareness about HIV screening and regular monitoring is promoting early detection and treatment-seeking behavior among at-risk groups and general population. Governments are also undertaking various programs to increase awareness and screening rates, thus benefitting the HIV diagnostics market growth in Asia Pacific.

Segment Analysis
Asia Pacific HIV Diagnostics Market
The Asia Pacific HIV Diagnostics Market is expected to be dominated by HIV screening segment during the forecast period. HIV screening segment accounted for the largest market share in 2024, owing to rising awareness regarding HIV/AIDS testing and availability of various HIV screening kits and tests in the region. Rising cases of HIV infections and high risk of population contracting the virus has contributed to the growth of this segment.

Key Takeaways
The global Asia Pacific HIV Diagnostics Market is expected to witness high growth.

Regional analysis related content comprises the Asia Pacific region is projected to witness the fastest growth over the forecast period. Countries like India, China, South Korea, Australia and others are witnessing rising awareness amongst people regarding HIV/AIDS which is contributing to the demand for diagnostics.

Key players related content comprises Key players operating in the Asia Pacific HIV Diagnostics Market are Abbott Laboratories, Merck KGaA, F. Hoffmann-La Roche AG, Atomo Diagnostics, Siemens Healthineers, Inc., bioLytical Laboratories Inc., MedMira Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., and Danaher Corporation.

Comments

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure